PL1827484T3 - Nasilenie tworzenia mikronaczyń wewnątrz światła naczynia w celu ułatwienia przeprowadzenia prowadnika przez przewlekłą całkowitą niedrożność - Google Patents

Nasilenie tworzenia mikronaczyń wewnątrz światła naczynia w celu ułatwienia przeprowadzenia prowadnika przez przewlekłą całkowitą niedrożność

Info

Publication number
PL1827484T3
PL1827484T3 PL05816353T PL05816353T PL1827484T3 PL 1827484 T3 PL1827484 T3 PL 1827484T3 PL 05816353 T PL05816353 T PL 05816353T PL 05816353 T PL05816353 T PL 05816353T PL 1827484 T3 PL1827484 T3 PL 1827484T3
Authority
PL
Poland
Prior art keywords
intraluminal
augmentation
guide wire
chronic total
wire crossing
Prior art date
Application number
PL05816353T
Other languages
English (en)
Inventor
Bradley H Strauss
Amit Segev
Original Assignee
Matrizyme Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrizyme Pharma Corp filed Critical Matrizyme Pharma Corp
Publication of PL1827484T3 publication Critical patent/PL1827484T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Materials For Medical Uses (AREA)
PL05816353T 2004-12-02 2005-12-02 Nasilenie tworzenia mikronaczyń wewnątrz światła naczynia w celu ułatwienia przeprowadzenia prowadnika przez przewlekłą całkowitą niedrożność PL1827484T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63226704P 2004-12-02 2004-12-02
EP05816353.6A EP1827484B1 (en) 2004-12-02 2005-12-02 Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions
PCT/CA2005/001838 WO2006058434A1 (en) 2004-12-02 2005-12-02 Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions

Publications (1)

Publication Number Publication Date
PL1827484T3 true PL1827484T3 (pl) 2016-05-31

Family

ID=36564726

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05816353T PL1827484T3 (pl) 2004-12-02 2005-12-02 Nasilenie tworzenia mikronaczyń wewnątrz światła naczynia w celu ułatwienia przeprowadzenia prowadnika przez przewlekłą całkowitą niedrożność

Country Status (7)

Country Link
US (1) US8512311B2 (pl)
EP (1) EP1827484B1 (pl)
JP (1) JP2008521523A (pl)
CA (1) CA2589523C (pl)
ES (1) ES2542987T3 (pl)
PL (1) PL1827484T3 (pl)
WO (1) WO2006058434A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1827484T3 (pl) 2004-12-02 2016-05-31 Matrizyme Pharma Corp Nasilenie tworzenia mikronaczyń wewnątrz światła naczynia w celu ułatwienia przeprowadzenia prowadnika przez przewlekłą całkowitą niedrożność
WO2008103336A1 (en) * 2007-02-21 2008-08-28 Cook Incorporated Methods for intravascular engraftment in heart
US8747297B2 (en) 2009-03-02 2014-06-10 Olympus Corporation Endoscopic heart surgery method
JP5415925B2 (ja) 2009-03-02 2014-02-12 オリンパス株式会社 内視鏡
JP5567840B2 (ja) 2009-09-22 2014-08-06 オリンパス株式会社 細胞注入デバイス
WO2011037068A1 (ja) 2009-09-22 2011-03-31 オリンパス株式会社 空間確保デバイス
US9072490B2 (en) * 2010-12-20 2015-07-07 Toshiba Medical Systems Corporation Image processing apparatus and image processing method
US9642586B2 (en) * 2014-08-18 2017-05-09 Siemens Aktiengesellschaft Computer-aided analysis of medical images
CN113870177B (zh) * 2021-08-13 2025-07-22 首都医科大学附属北京安贞医院 一种血管闭塞病变的冠脉cta处理方法和装置

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6152141A (en) * 1994-07-28 2000-11-28 Heartport, Inc. Method for delivery of therapeutic agents to the heart
WO1997023256A1 (en) * 1995-12-22 1997-07-03 Localmed, Inc. Localized intravascular delivery of growth factors for promotion of angiogenesis
US5866561A (en) * 1997-08-21 1999-02-02 Scimed Life Systems, Inc. Local delivery of estrogen for angiogenesis
US6295990B1 (en) * 1998-02-03 2001-10-02 Salient Interventional Systems, Inc. Methods and systems for treating ischemia
US6044845A (en) * 1998-02-03 2000-04-04 Salient Interventional Systems, Inc. Methods and systems for treating ischemia
US20030149997A1 (en) * 1999-02-19 2003-08-07 Hageman Gregory S. Diagnostics and therapeutics for arterial wall disruptive disorders
EP1294422B1 (en) * 2000-03-20 2010-02-24 Cordis Corporation Medical System for Reducing Vascular Occlusions
US20010031981A1 (en) * 2000-03-31 2001-10-18 Evans Michael A. Method and device for locating guidewire and treating chronic total occlusions
US6569129B1 (en) * 2000-09-13 2003-05-27 Mayo Foundation For Medical Education And Research Biological revascularization
US6602241B2 (en) * 2001-01-17 2003-08-05 Transvascular, Inc. Methods and apparatus for acute or chronic delivery of substances or apparatus to extravascular treatment sites
US6660034B1 (en) 2001-04-30 2003-12-09 Advanced Cardiovascular Systems, Inc. Stent for increasing blood flow to ischemic tissues and a method of using the same
US7452532B2 (en) * 2001-09-30 2008-11-18 Scicotec Gmbh Transluminal application of adult stem cells for body organ tissue repair
PT1438065E (pt) * 2001-10-01 2013-01-24 Matrizyme Pharma Corp Utilização de colagenase para facilitar a passagem de um passa-fios em oclusões crónicas das artérias
US7758636B2 (en) * 2002-09-20 2010-07-20 Innovational Holdings Llc Expandable medical device with openings for delivery of multiple beneficial agents
US7326238B1 (en) * 2002-09-30 2008-02-05 Abbott Cardiovascular Systems Inc. Method and apparatus for treating vulnerable plaque
CA2505576A1 (en) * 2002-11-08 2004-05-27 Conor Medsystems, Inc. Expandable medical device and method for treating chronic total occlusions with local delivery of an angiogenic factor
EP1786502A2 (en) * 2004-07-15 2007-05-23 Incumed Device and method for treating a blood vessel
PL1827484T3 (pl) 2004-12-02 2016-05-31 Matrizyme Pharma Corp Nasilenie tworzenia mikronaczyń wewnątrz światła naczynia w celu ułatwienia przeprowadzenia prowadnika przez przewlekłą całkowitą niedrożność

Also Published As

Publication number Publication date
WO2006058434A1 (en) 2006-06-08
EP1827484B1 (en) 2015-06-17
US8512311B2 (en) 2013-08-20
CA2589523C (en) 2016-01-05
JP2008521523A (ja) 2008-06-26
EP1827484A1 (en) 2007-09-05
US20070154555A1 (en) 2007-07-05
ES2542987T3 (es) 2015-08-13
EP1827484A4 (en) 2009-07-29
CA2589523A1 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
IL198829A0 (en) Gm-csf antagonist use in treating chronic inflammatory diseases
EP2010065A4 (en) MECHANICAL BARRIER IN WOUND HEALING
TWI348499B (en) Electroless copper and redox couples
GB2428882B (en) Method of producing pitch fractionizations in semiconductor technology
IL180759A0 (en) Indazoles useful in treating cardiovascular diseases
ZA201006069B (en) Methods of treating chronic pain
PL2061385T3 (pl) Urządzenie do zabiegów naczyniowych
GB0809482D0 (en) Catheter guide wire
GB0720980D0 (en) Improvements in or relating to cubicle curtains
DE602007005376D1 (de) Draht-im-kanal-supraleiter
PT2139373T (pt) Máquina de lavar louça e respetivo elemento de insonorização
PT1438065E (pt) Utilização de colagenase para facilitar a passagem de um passa-fios em oclusões crónicas das artérias
EP1827484A4 (en) INCREASE IN THE FORMATION OF AN INTRALUMINAL MICROCHAPTER TO FACILITATE THE PASSAGE OF A GUIDEWIRE IN THE CHRONIC TOTAL OCCLUSIONS
PT2679278T (pt) Composições dermatológicas que compreendem sulfato de heparano
GB0610124D0 (en) Natural alternatives to r410a refrigerant
TWI369213B (en) Therapeutic gastrodia extracts
PL2146706T3 (pl) Zastosowanie dimiracetamu do leczenia chronicznego bólu
GB0623790D0 (en) Improvements in or relating to curtain walling
HU0600940D0 (en) Playing device improving motion and coordination
IL181416A0 (en) Use of il-6 in vascular complications
PL1772560T3 (pl) Ekran chroniący przed hałasem ustawiany przy trasach szybkiego ruchu
ZA200805882B (en) Resistance to physiological disorders in lettuce
IL192622A0 (en) Resistance to physiological disorders in lettuce
EP2056839A4 (en) COMBINED APPROACHES FOR THE TREATMENT OF CANCER
GB0602224D0 (en) Composition for promoting vascular smooth muscle relaxation